Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to -$567.7 million.

  • Revolution Medicines' Free Cash Flow fell 57.28% to -$210.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$777.1 million, marking a year-over-year decrease of 41.00%. This contributed to the annual value of -$567.7 million for FY2024, which is 58.45% down from last year.
  • Per Revolution Medicines' latest filing, its Free Cash Flow stood at -$567.7 million for FY2024, which was down 58.45% from -$358.3 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Free Cash Flow ranged from a high of -$103.0 million in FY2020 and a low of -$567.7 million during FY2024.
  • Its 3-year average for Free Cash Flow is -$387.1 million, with a median of -$358.3 million in 2023.
  • Data for Revolution Medicines' Free Cash Flow shows a maximum YoY slumped of 97.29% (in 2020) over the last 5 years.
  • Over the past 5 years, Revolution Medicines' Free Cash Flow (Yearly) stood at -$103.0 million in 2020, then crashed by 49.24% to -$153.7 million in 2021, then crashed by 53.03% to -$235.2 million in 2022, then tumbled by 52.33% to -$358.3 million in 2023, then slumped by 58.45% to -$567.7 million in 2024.